药物输送中的光响应分子的人类反策略:利用GPT-2和时间依赖密度功能理论计算
Junjie Hu1, Peng Wu2, Shiyi Wang3
1Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
Pharmaceutics
|August 29, 2024
概括
研究人员使用生成预训练变压器 (GPT) 模型来设计紫外线光敏感分子,用于先进的药物输送. 这种方法将人工智能与量子化学相结合,用于精确的光触发治疗开发.
科学领域:
- 药物输送和纳米技术
- 化学中的人工智能.
- 计算化学计算化学
背景情况:
- 光响应药物递送提供了精确的,对药物释放的非侵入性控制.
- 生成式预训练变压器 (GPT) 模型显示了设计新型分子结构的潜力.
研究的目的:
- 使用GPT-2开发对紫外线光敏感的分子.
- 预测和验证激发波长和激发状态属性.
- 将人工智能驱动的分子设计与来自人类反的强化学习 (RLHF) 结合起来.
主要方法:
- 在QM7b数据集上微调GPT-2模型以创建UV-GPT模型.
- 采用库伦矩阵作为分子描述器来预测激发波长.
- 进行量子化学模拟以验证激发状态属性.
主要成果:
- 成功生成了对紫外线光敏感的分子.
- 使用库伦矩阵描述器准确预测激发波长.
- 通过严格的量子化学模拟来验证激发状态属性.
结论:
- 可以有效地应用GPT技术来设计用于智能药物递送的光响应分子.
- 该研究为优化光触发应用的化学结构提供了见解.
- 人工智能和RLHF的整合增强了先进治疗系统的发展.
相关概念视频
Pore Transport and Ion-Pair Transport
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Nonlinear Pharmacokinetics: Role of Transporters
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...


